1. Home
  2. SABS vs LEDS Comparison

SABS vs LEDS Comparison

Compare SABS & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • LEDS
  • Stock Information
  • Founded
  • SABS 2014
  • LEDS 2005
  • Country
  • SABS United States
  • LEDS Taiwan
  • Employees
  • SABS N/A
  • LEDS N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • LEDS Semiconductors
  • Sector
  • SABS Health Care
  • LEDS Technology
  • Exchange
  • SABS Nasdaq
  • LEDS Nasdaq
  • Market Cap
  • SABS 15.8M
  • LEDS 16.1M
  • IPO Year
  • SABS N/A
  • LEDS 2010
  • Fundamental
  • Price
  • SABS $2.35
  • LEDS $2.43
  • Analyst Decision
  • SABS Strong Buy
  • LEDS
  • Analyst Count
  • SABS 4
  • LEDS 0
  • Target Price
  • SABS $9.50
  • LEDS N/A
  • AVG Volume (30 Days)
  • SABS 427.8K
  • LEDS 30.8K
  • Earning Date
  • SABS 11-05-2025
  • LEDS 11-26-2025
  • Dividend Yield
  • SABS N/A
  • LEDS N/A
  • EPS Growth
  • SABS N/A
  • LEDS N/A
  • EPS
  • SABS N/A
  • LEDS N/A
  • Revenue
  • SABS $114,698.00
  • LEDS $31,108,000.00
  • Revenue This Year
  • SABS N/A
  • LEDS N/A
  • Revenue Next Year
  • SABS N/A
  • LEDS N/A
  • P/E Ratio
  • SABS N/A
  • LEDS N/A
  • Revenue Growth
  • SABS N/A
  • LEDS 485.62
  • 52 Week Low
  • SABS $1.00
  • LEDS $1.09
  • 52 Week High
  • SABS $6.60
  • LEDS $3.16
  • Technical
  • Relative Strength Index (RSI)
  • SABS 54.67
  • LEDS 57.47
  • Support Level
  • SABS $2.20
  • LEDS $2.02
  • Resistance Level
  • SABS $2.60
  • LEDS $2.67
  • Average True Range (ATR)
  • SABS 0.19
  • LEDS 0.20
  • MACD
  • SABS 0.02
  • LEDS -0.01
  • Stochastic Oscillator
  • SABS 68.00
  • LEDS 58.55

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

Share on Social Networks: